Step Pharma Aims To Become CTP Synthase 1 Leader, Starting With Aggressive Lymphoma
Executive Summary
Emerging Company Profile: The French firm, which is developing the lead CTP synthase 1 inhibitor in the pipeline, plans to address a range of cancers with its highly selective approach.